The global surrogacy market reached a size of USD 204.6 Million in 2025 and is projected to expand to USD 329.2 Million by 2034, growing at a CAGR of 5.43% during 2026-2034. Market growth is fueled by rising infertility rates, increased societal acceptance of surrogacy, advancements in assisted reproductive technologies, and favorable government payment policies. The market is also impacted by fertility tourism and legal frameworks supporting surrogacy. 

Study Assumption Years

• Base Year: 2025
• Historical Years: 2020-2025
• Forecast Period: 2026-2034

Surrogacy Market Key Takeaways

• The global surrogacy market size was valued at USD 194.0 Million in 2024.
• The market is expected to exhibit a CAGR of 5.43% during 2026-2034.
• The forecast period for this report is from 2026 to 2034.
• Growth is driven by the increasing prevalence of infertility, growing awareness and acceptance of surrogacy, and legal developments creating transparent safeguards.
• Advances in IVF treatments have increased success rates, fueling the demand.
• North America dominates due to its supportive legal framework, advanced medical facilities, and high public acceptance.
• Fertility clinics are the leading service providers, offering comprehensive surrogacy services and supporting medical innovation.

Sample Request Link: 

https://www.imarcgroup.com/surrogacy-market/requestsample

Market Growth Factors

Rising infertility and delayed parenthood are expanding the addressable pool for surrogacy services. Lifestyle stress, obesity, PCOS, endometriosis, uterine disorders, and male-factor infertility increase demand for assisted reproduction, while more couples postpone childbirth into their 30s and 40s, when fertility declines and pregnancy risks rise. As ART pathways mature, intended parents increasingly choose gestational surrogacy to reduce medical complications and improve live-birth odds. IVF with ICSI supports severe male-factor cases, and embryo freezing enables planned transfers, improving outcomes. Fertility clinics also bundle stimulation, retrieval, and transfer packages, making costs more predictable. Together, these factors lift inquiry volumes and convert more IVF patients into surrogacy candidates, especially for recurrent IVF failure.

Evolving family structures and greater social acceptance are accelerating adoption beyond traditional couples. Growing LGBTQ+ parenthood, single intended parents, and blended families are seeking dependable routes to genetic or legally recognized parenthood, making gestational surrogacy a preferred option. Online education, patient communities, and teleconsultations reduce stigma and improve access to information about clinics, contracts, and costs. Demand is also rising for cross-border treatment where regulations, expertise, or affordability are favorable, pushing agencies to coordinate medical travel. Improved legal frameworks, clearer parentage orders, and stronger consent standards in some regions further increase confidence. This broadening user base sustains multi-year market expansion across hospitals and fertility clinics worldwide during the 2026-2034 period.

Expansion of specialized providers and supporting technologies is improving the end-to-end surrogacy experience, boosting success rates and confidence. Fertility clinics and hospitals are building dedicated surrogacy programs with standardized surrogate screening, counseling, medical monitoring, and neonatal partnerships. Technology upgrades such as advanced IVF labs, optimized stimulation protocols, ICSI capability, genetic testing options, and embryo cryopreservation reduce cycle cancellations and enable better embryo selection. Digital case management tools streamline matching, documentation, and appointment adherence across stakeholders. Meanwhile, competition among clinics raises service quality, expands regional availability, and shortens wait times. These operational gains increase throughput per center and grow the overall market for agencies, labs, and providers at scale over 2026-2034.

Market Segmentation

By Type

• Gestational Surrogacy: This segment dominates the market, involving a surrogate carrying a pregnancy genetically unrelated to her, offering benefits in reducing legal and psychological challenges. It caters to individuals and couples with reproductive issues or same-sex couples, driven by advancements in IVF accuracy increasing success rates.
• Traditional Surrogacy: Included as a segment but less dominant than gestational surrogacy.

By Technology

• IVF with ICSI: This segment holds the largest market share, employing intracytoplasmic sperm injection to overcome male infertility by injecting a single sperm directly into an egg, enhancing fertilization success and extending surrogacy applicability.
• IVF without ICSI: Present as a segment.
• Intrauterine Insemination: Included as a segment.

By Service Provider

• Fertility Clinics: The largest segment, fertility clinics provide advanced reproductive technologies, full medical assessments, and comprehensive treatment and monitoring, collaborating closely with legal and surrogacy agencies to facilitate successful pregnancies.
• Hospitals: Included as a segment.
• Others: Included as a segment.

Regional Insights

North America leads the surrogacy market, driven by a strong legal framework protecting intended parents, surrogates, and resultant children. The region’s advanced fertility treatment centers, high success and safety rates, and broad public acceptance position it as the dominant market globally. The multi-ethnic population and evolving perceptions of family contribute to sustained growth and attractiveness for domestic and international intended parents.

Recent Developments & News

In June 2021, Circle Surrogacy & Egg Donation launched the “A Lifetime of Pride and Joy” campaign to promote family equality and fertility care accessibility for the LGBTQ+ community. In June 2023, Nova IVF Fertility announced a plan to expand to 100 centers across India in four years, enhancing access to fertility care. In October 2022, Ovation Fertility partnered with Genomic Prediction to advance genetic testing capabilities for fertility and family planning.

Key Players

• Bourn Hall Fertility Clinic
• Care Fertility
• Circle Surrogacy
• Extraordinary Conceptions
• Growing Generations
• Houston Fertility Center
• IVIRMA Global
• Kindbody
• Max Healthcare
• New Hope Fertility Clinic
• Nova IVF
• Ovation Fertility

Get Custom Market Research Report for Your Business:

https://www.imarcgroup.com/request?type=report&id=5298&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302